Literature DB >> 5640374

Natural antibody in mammalian serum reacting with an antigen in some leptospires.

S Faine, J N Carter.   

Abstract

Serum from normal mammals agglutinated and immobilized nonpathogenic Leptospira biflexa and agglutinated avirulent lines of pathogenic serotypes L. icterohaemorrhagiae and L. zanoni. Virulent lines of L. icterohaemorrhagiae and L. zanoni were not affected, nor were any of three strains of L. pomona, one of which was avirulent. The active principle in serum was a beta-macroglobulin which was heat-labile and reduced by 2-mercaptoethanol, and acted in conjunction with complement and lysozyme; it was absorbable from serum by Formalin-treated susceptible leptospires. The Formalin-stable receptor antigen, named "Z antigen," is associated with virulence rather than pathogenicity, but may not be a determinant of virulence.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5640374      PMCID: PMC252014          DOI: 10.1128/jb.95.2.280-285.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  11 in total

1.  [MACROMOLECULAR NATURE OF AN ANTIBODY OF LEPTOSPIROSIS AUSTRALIS].

Authors:  L HARTMANN; S FILITTI WURMSER; Y JACQUOT ARMAN; M MAILLOUX; D HUREZ; R FAUVERT
Journal:  Biochim Biophys Acta       Date:  1964-02-10

2.  [IMMUNOELECTROPHORETIC ANALYSIS, IN GEL MEDIUM, OF SERUM PROTEINS IN LEPTOSPIROSIS].

Authors:  C LATASTE-DOROLLE; A EYQUEM; J F BURI
Journal:  Ann Inst Pasteur (Paris)       Date:  1964-04

3.  VIRULENCE-LINKED COLONIAL AND MORPHOLOGICAL VARIATION IN LEPTOSPIRA.

Authors:  S FAINE; J VANDERHOEDEN
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

4.  ANTILEPTOSPIRAL ACTIVITY OF NORMAL SERUM.

Authors:  R C JOHNSON; L H MUSCHEL
Journal:  J Bacteriol       Date:  1965-06       Impact factor: 3.490

5.  STUDIES ON MOUSE ANTIBODIES. II. MERCAPTOETHANOL-SENSITIVE 7 S ANTIBODIES IN MOUSE ANTISERA TO PROTEIN ANTIGENS.

Authors:  F L ADLER
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

6.  The nature of antibodies synthesized during the immune response to Leptospira biflexa.

Authors:  N D Hocker; D C Bauer
Journal:  J Immunol       Date:  1965-11       Impact factor: 5.422

7.  Chromatographic analysis and sulfhydryl sensitivity of antileptospira agglutinins in rabbit and human sera.

Authors:  R M Pike; H L McBrayer; M L Schulze; C H Chandler
Journal:  Proc Soc Exp Biol Med       Date:  1965-12

8.  Antileptospiral activity of serum. II. Leptospiral virulence factor.

Authors:  R C Johnson; V G Harris
Journal:  J Bacteriol       Date:  1967-02       Impact factor: 3.490

9.  Differentiation of pathogenic and saprophytic letospires. I. Growth at low temperatures.

Authors:  R C Johnson; V G Harris
Journal:  J Bacteriol       Date:  1967-07       Impact factor: 3.490

10.  Antileptospiral activity of serum. I. Normal and immune serum.

Authors:  R C Johnson; L H Muschel
Journal:  J Bacteriol       Date:  1966-04       Impact factor: 3.490

View more
  5 in total

1.  Heated sheep or horse serum substitute for rabbit serum in culture media for Leptospira.

Authors:  S Faine
Journal:  Appl Microbiol       Date:  1968-03

2.  Interaction of leptospires with human polymorphonuclear neutrophils.

Authors:  B Wang; J Sullivan; G W Sullivan; G L Mandell
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

3.  Antileptospiral activity in lower-vertebrate sera.

Authors:  N W Charon; R C Johnson; L H Muschel
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

4.  A card test for the serodiagnosis of human leptospirosis.

Authors:  J M Bragger; B Adler
Journal:  J Clin Pathol       Date:  1976-03       Impact factor: 3.411

5.  Serum antileptospiral agglutinins in freshwater turtles from Southern Brazil.

Authors:  Everton F Silva; Núbia Seyffert; Gustavo M Cerqueira; Karl P Leihs; Daniel A Athanazio; Ana L S Valente; Odir A Dellagostin; Claudiomar S Brod
Journal:  Braz J Microbiol       Date:  2009-06-01       Impact factor: 2.476

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.